Robin Hwang, PhD ICP Consulting

Robin is the founder of ICP Consulting Corp., specializing in injectable combination products.

Prior to consulting, he was a Vice President in Drug Delivery Devices at Halozyme and led the drug delivery efforts, targeting subcutaneous high-volume devices in combination with hyaluronidase. Prior to Halozyme, he was a Director at Amgen and led the development and the commercialization of three combination products. Before coming to Amgen, Robin worked at Becton Dickinson Research Center and GE Plastics.

Robin received his Bachelor degree from NCKU in Taiwan, Master degree in Chem Eng from IIT and a PhD degree in Chem Eng/Polymer Sci & Eng from UMASS-Amherst.